{
  "primary": "PRPF19",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 interacts with the Pre-mRNA-processing factor 19 (PRPF19) as part of the spliceosome complex.",
  "functions": [
    {
      "function": "Mutant ATXN3 Stability",
      "arrow": "inhibits",
      "cellular_process": "Pre-mRNA-processing factor 19 (PRPF19) is an E3 ubiquitin ligase that directly interacts with the expanded polyglutamine (polyQ) form of Ataxin-3. This interaction occurs in the nucleus and is a key part of the cellular protein quality control system.",
      "effect_description": "PRPF19, through its E3 ligase activity, catalyzes the attachment of poly-ubiquitin chains to the toxic ATXN3-polyQ protein. This ubiquitination marks the mutant ATXN3 for degradation by the proteasome, thereby reducing its cellular levels and mitigating its cytotoxic effects.",
      "biological_consequence": [
        "Expanded ATXN3-polyQ is present in the nucleus → PRPF19 binds to ATXN3-polyQ via its C-terminal WD40 domain → PRPF19 acts as an E3 ligase, promoting poly-ubiquitination of ATXN3-polyQ → Ubiquitinated ATXN3-polyQ is targeted for proteasomal degradation → Cellular levels of toxic ATXN3-polyQ are reduced → Neurodegeneration is suppressed."
      ],
      "specific_effects": [
        "Directly interacts with expanded polyQ ATXN3.",
        "Promotes poly-ubiquitination of mutant ATXN3.",
        "Facilitates the proteasomal clearance of mutant ATXN3."
      ],
      "evidence": [
        {
          "paper_title": "A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3",
          "journal": "Cell Death & Disease",
          "year": 2021,
          "relevant_quote": "In this study, we identified an E3 ligase, pre-mRNA processing factor 19 (Prpf19/prp19), that modulates expanded ataxin-3 (ATXN3-polyQ), disease protein of SCA3, induced neurodegeneration in both mammalian and Drosophila disease models. We further showed that Prpf19/prp19 promotes poly-ubiquitination and degradation of mutant ATXN3-polyQ protein. Our data further demonstrated the nuclear localization of Prpf19/prp19 is essential for eliciting its modulatory function towards toxic ATXN3-polyQ protein.",
          "pmid": "33542212"
        }
      ],
      "pathway": {
        "name": "Protein Stability Regulation",
        "canonical_name": "Protein Stability Regulation",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "33542212"
      ],
      "interaction_effect": "inhibits",
      "interaction_direction": "primary_to_main",
      "function_effect": "inhibition"
    }
  ],
  "arrow": "binds",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input claim is a 'Mechanistic Opposite'. The primary literature shows that PRPF19 is an E3 ubiquitin ligase that acts upon mutant ATXN3, rather than ATXN3 deubiquitinating spliceosomal components via PRPF19. PRPF19 recognizes and promotes the poly-ubiquitination and subsequent proteasomal degradation of expanded, toxic ATXN3-polyQ, serving a neuroprotective role.",
  "mechanism": "Pre-mRNA-processing factor 19 (PRPF19) is an E3 ubiquitin ligase that directly interacts with the expanded polyglutamine (polyQ) form of Ataxin-3. This interaction occurs in the nucleus and is a key part of the cellular protein quality control system.",
  "effect": "PRPF19, through its E3 ligase activity, catalyzes the attachment of poly-ubiquitin chains to the toxic ATXN3-polyQ protein. This ubiquitination marks the mutant ATXN3 for degradation by the proteasome, thereby reducing its cellular levels and mitigating its cytotoxic effects.",
  "summary": "ATXN3 inhibits PRPF19 to modulate regulation of mutant atxn3 stability, ultimately affecting neurodegeneration is suppressed.",
  "evidence": [
    {
      "paper_title": "A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3",
      "journal": "Cell Death & Disease",
      "year": 2021,
      "relevant_quote": "In this study, we identified an E3 ligase, pre-mRNA processing factor 19 (Prpf19/prp19), that modulates expanded ataxin-3 (ATXN3-polyQ), disease protein of SCA3, induced neurodegeneration in both mammalian and Drosophila disease models. We further showed that Prpf19/prp19 promotes poly-ubiquitination and degradation of mutant ATXN3-polyQ protein. Our data further demonstrated the nuclear localization of Prpf19/prp19 is essential for eliciting its modulatory function towards toxic ATXN3-polyQ protein."
    }
  ],
  "pathways": [
    {
      "name": "Protein Stability Regulation",
      "canonical_name": "Protein Stability Regulation",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "binding",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--binds-- PRPF19:",
  "protein_a": "ATXN3",
  "protein_b": "PRPF19",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-30T15:37:50.137478Z",
  "last_updated": "2025-11-30T15:37:50.137478Z"
}